Left ventricular remodeling of hypertrophic cardiomyopathy - Longitudinal observation in a rural community

Circulation Journal

Volumn 70, Issue 12, 2006, Pages 1543-1549

  Kitaoka, Hiroaki ^a   Kubo, Toru ^a   Okawa, Makoto ^a   Hitomi, Nobuhiko ^a   Furuno, Takashi ^a   Doi, Yoshinori L ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Heart failure; Hypertrophic cardiomyopathy; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE REMODELING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; PROGNOSIS; STROKE; SUDDEN DEATH; SURVIVAL RATE;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; FEMALE; HUMANS; JAPAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; RURAL POPULATION; VENTRICULAR DYSFUNCTION; VENTRICULAR REMODELING;

EID: 33751426386     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1543     Document Type: Article

References (32)

1. Maron BJ. Hypertrophic cardiomyopathy: A systematic review. JAMA 2002; 287: 1308-1320.
2. Maron BJ. Hypertrophic cardiomyopathy. Lancet 1997; 350: 127-133.
3. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: Clinical spectrum and treatment. Circulation 1995; 92: 1680-1692.
4. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336: 775-785.
5. McKenna WJ, Deanfield JE, Faruqui A, England D, Oakley MC, Goodwin JF. Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981; 47: 532-538.
6. Maron BJ, Savage DD, Wolfson JK, Epstein SE. Progostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study. Am J Cardiol 1981; 48: 252-257.
7. Romeo F, Pelliccia F, Cristofani R, Martuscelli CE, Reale A. Hypertrophic cardiomyopathy: Is a left ventricular outflow tract gradient a major prognostic determinant? Eur Heart J 1990; 11: 233-240.
8. Seiler C, Hess OM, Schoenbeck M, Turina J, Jenni R, Turina M, et al. Long- term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: A retrospective study. J Am Coll Cardiol 1991; 17: 634-642.
9. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999; 281: 650-655.
10. Kofflard MJM, Ten Cate FJ, van der Lee C, van Domberg RT. Hypertrophic cardiomyopathy in a large community-based population: Clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol 2003; 41: 987-993.
11. Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: Clinical course and outcome in an unselected regional population. J Am Coll Cardiol 1995; 26: 1529-1536.
12. Cecchi F, Olivotto I, Betocchi S, Rapezzi C, Conte MR, Sinagra G, et al. The Italian registry for hypertrophic cardiomyopathy: A nationwide survey. Am Heart J 2005; 150: 947-954.
13. Kyriakids M, Triposkiadis F, Anastasakis A, Theopistou A, Tocta R, Barbetseas J, et al. Hypertrophic cardiomyopathy in Greece. Chest 1998; 114: 1091-1096.
14. Spirito P, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol 1987; 60: 123-139.
15. Maron BJ, Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol 1998; 81: 1339-1344.
16. Thaman R, Gimeno JR, Murphy RT, Kubo T, Sachdev B, Mogensen J, et al. Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy. Heart 2005; 91: 920-925.
17. Biagini E, Coccolo F, Ferlito M, Perugini E, Rocchi G, Bacchireggiani L, et al. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy. J Am Coll Cardiol 2005; 46: 1543-1550.
18. Hina K, Kusachi S, Iwasaki K, Nogami K, Moritani H, Kita T, et al. Progression of left ventricular enlargement in patients with hypertrophic cardiomyopathy: Incidence and prognostic value. Clin Cardiol 1993; 16: 403-407.
19. Olivotto I, Cecchi F, Gistri R, Lorenzoni R, Chiriatti G, Girolami F, et al. Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopath. J Am Coll Cardiol 2006; 47: 1043-1048.
20. Kubo T, Kitaoka H, Okawa M, Matsumura Y, Hitomi N, Yamasaki N, et al. Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac myosin-binding protein C gene among Japanese. J Am Coll Cardiol 2005; 46: 1737-1743.
21. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of the distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A wide-angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 1981; 48: 418-428.
22. Okawa M, Kitaoka H, Matsumura Y, Kubo T, Yamasaki N, Furuno T, et al. Functional assessment by myocardial performance index (Tei Index) correlates with plasma brain natriuretic peptide concentration in patients with hypertrophic cardiomyopathy. Circ J 2005; 69: 951-957.
23. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995; 26: 1699-1708.
24. Hirota T, Kitaoka H, Kubo T, Okawa M, Furuno T, Doi YL. Morphologic characteristics of hypertrophic cardiomyopathy of the elderly with cardiac myosin-binding protein C gene mutations. Circ J 2006; 70: 875-879.
25. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, et al. Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol 2000; 36: 2212-2218.
26. Olivotto I, Gistri R, Petrone P, Pedemonte E, Vargiu D, Cecchi F. Maximal left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003; 41: 315-321.
27. Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, et al. Epidemiology of hypertrophic cardiomyopathy-related death. Circulation 2002; 102: 858-864.
28. Nihoyannopoulos P, Karatasakis G, Frenneaux M, McKenna WJ, Oakley CM. Diastolic function in hypertrophic cardiomyopathy: Relation to exercise capacity. J Am Coll Cardiol 1992; 19: 536-540.
29. Briguori C, Betocchi S, Romana M, Manganelli F, Losi MA, Ciampi Q, et al. Excesise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function. Am J Cardiol 1999; 84: 309-315.
30. Kato T, Noda A, Izawa H, Nishizawa T, Somura F, Yamada A, et al. Myocardial velosity gradient as a noninvasively determined index of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003; 42: 278-285.
31. Matsumura Y, Elloott PM, Virdee MS, Sorajja P, Doi Y, McKenna WJ. Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: Relation to symptoms and exercise capacity. Heart 2002; 87: 247-251.
32. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001; 104: 2517-2524.